- Yidu Technology launched an AI training and inference all-in-one machine with Ascend AI in late September 2026, driving a daily share price surge of over 10 percent and boosting attention on the Hong Kong stock market's medical AI sector.
- Multiple non-traditional or smaller-cap Hong Kong listed companies, including Sunshine City Pharmaceutical, GenScript, and Xinyi Solar, are actively expanding into AI-assisted drug R and D, gene synthesis, and medical equipment coatings.
- These decentralized technological breakthroughs are reshaping the market's technical landscape, prompting analysts to re-evaluate the innovation potential of edge stocks in the medical AI field.